| 000 | 01199 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514204342.0 | ||
| 264 | 0 | _c20041209 | |
| 008 | 200412s 0 0 eng d | ||
| 022 | _a1054-3589 | ||
| 024 | 7 |
_a10.1016/S1054-3589(04)51007-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSievers, Eric L | |
| 245 | 0 | 0 |
_aNative antibody and antibody-targeted chemotherapy for acute myeloid leukemia. _h[electronic resource] |
| 260 |
_bAdvances in pharmacology (San Diego, Calif.) _c2004 |
||
| 300 |
_a169-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAcute Disease _xtherapy |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aAntigens, CD _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Differentiation, Myelomonocytic _ximmunology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoconjugates _xadverse effects |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xdrug therapy |
| 650 | 0 | 4 | _aSialic Acid Binding Ig-like Lectin 3 |
| 773 | 0 |
_tAdvances in pharmacology (San Diego, Calif.) _gvol. 51 _gp. 169-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1054-3589(04)51007-4 _zAvailable from publisher's website |
| 999 |
_c15156692 _d15156692 |
||